
How ‘Pharaoh's curse' may help fight CANCER after leukaemia-battling chemical found in fungus linked to King Tut deaths
PHARAOH'S GIFT How 'Pharaoh's curse' may help fight CANCER after leukaemia-battling chemical found in fungus linked to King Tut deaths
Click to share on X/Twitter (Opens in new window)
Click to share on Facebook (Opens in new window)
A TOXIC fungus linked to the deaths of researchers who opened King Tutankhamun's tomb may help fight cancer.
The poisonous fungus found growing inside the ancient tombs is believed to have struck down a team of 10 archaeologists in a theory known as "Pharaoh's Curse".
Sign up for Scottish Sun
newsletter
Sign up
3
King Tut's tomb was teaming with a fungus believed to have killed a group of researchers
Credit: PA:Press Association
3
The poisonous fungus has been found to contain properties that could tackle the division of cancer cells
3
Ingesting yellow spores of the fungus has been linked to lung disease
Credit: PA:Press Association
The fungus crop - known as Aspergillus flavus - is believed to have been ingested by the researchers who then developed lung infections and died.
But now, in a miraculous turn of events, scientists think the toxic fungus could contain elements needed to attack blood cancer.
The fungus contains a "promising" protein that, when purified, could help battle leukaemia cells, they said.
According to their research, when combined with human cells, the protein is potent enough to disrupt the division of cancer cells.
Cancer is when abnormal cells divide in an uncontrolled way.
It starts when gene changes make one cell or a few cells begin to grow and multiply too much.
Sherry Gao, a professor at the University of Pennsylvania, enthused that this could be the start of "many more medicines derived from natural products".
She told The Times: "Fungi gave us penicillin. These results show that many more medicines derived from natural products remain to be found".
She added: "Nature has given us this incredible pharmacy. It's up to us to uncover its secrets.
"As engineers, we're excited to keep exploring, learning from nature and using that knowledge to design better solutions.'
Tourists gather around Tutankhamun's 'cursed' body
This comes as researchers at Case Western Reserve University and Cleveland Clinic, both in the US, developed a new type of jab to fight pancreatic cancer.
The vaccine uses tiny particles called nanoparticles to train the body's immune system to find and kill 'bad' cancer cells.
In early tests with animals and lab models of pancreatic ductal adenocarcinoma (PDAC), the most common and aggressive type of pancreatic cancer, more than half of the treated patients were completely cancer-free months after getting the vaccine.
The vaccine also encourages the body to create its own T cells, immune fighters specially trained to attack cancer, while building up 'immune memory' for longer-term protection.
Meanwhile, researchers in South Korea said they were able to revert cancerous cells back to a healthier stage.
The team believe they can prevent the progression by exploiting the moment before normal cells irreversibly transform into diseased cells.
Current cancer treatments focus on removing or destroying cancer cells through surgery, radiation or chemotherapy.
But the groundbreaking discovery could let cancer patients regain their healthy cells.
The scientists published their findings in the journal Advanced Science.
Co-author of the new research Kwang-Hyun Cho is a professor of biology at the Korea Advanced Institute of Science and Technology.
He said: "This study has revealed in detail, at the genetic network level, what changes occur within cells behind the process of cancer development, which has been considered a mystery until now.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Western Telegraph
36 minutes ago
- Western Telegraph
‘Groundbreaking' drug could slow down progression of type 1 diabetes
Teplizumab, which is already approved in the US, trains the immune system to stop attacking pancreatic cells, delaying the need for insulin by an average of three years. With type 1 diabetes, the immune system attacks insulin-producing cells in the pancreas, meaning blood sugar levels are no longer regulated by the body. If blood sugar is too high or low, it can cause serious health problems and even death. People with type 1 therefore need daily insulin. Dentist and mother-of-two, Hannah Robinson, from Devon, is the first adult in the UK to try the drug in the hope it can delay the condition. She is having treatment at the Royal Devon University Healthcare NHS Foundation Trust after discovering during pregnancy she was in the early stages of developing type 1. Hannah Robinson discovered during pregnancy she was in the early stages of developing type 1 diabetes (Family handout/Royal Devon University Healthcare NHS Foundation Trust/PA) A handful of people are being given the medicine on a case-by-case basis while it is reviewed for wider use on the NHS. The 36-year-old said: 'For me, this new drug offers more freedom and the chance to focus on my health before I have to start thinking differently and managing life as somebody needing daily insulin. 'This isn't just about what I eat or monitoring my glucose, it is also about having more control and not feeling defined by my condition. 'This treatment could potentially pave the way for a future cure for type 1 diabetes, which is incredible. I feel very lucky to be part of this.' The new drug teplizumab must be given at the earliest stage of the disease to be effective. Dr Nick Thomas, diabetes consultant and academic clinical lecturer at the University of Exeter, said: 'This new treatment represents a really exciting shift in how we manage type 1 diabetes. 'For the first time ever, we will be able to provide targeted treatment early enough in the process to alter the underlying immune process, aiming to slow down how quickly people need insulin. 'Approximately half of all type 1 diabetes cases develop in adulthood, and Hannah will be the first adult in the UK to receive this treatment. 'My hope is that in the future, we may be able to stop people with early type 1 diabetes from needing insulin at all.' Teplizumab, which is already approved in the US, trains the immune system to stop attacking pancreatic cells, delaying the need for insulin by up to three years (Royal Devon University Healthcare NHS Foundation Trust/PA) Experts at the Royal Devon and the University of Exeter are using genetics and other testing to spot people at high risk of developing type 1 diabetes. The hope is more people could be offered the drug to delay type 1. Dr Lucy Chambers, head of research impact and communications at Diabetes UK, said: 'For people in the early stages of type 1 diabetes, teplizumab offers a groundbreaking opportunity to buy them precious extra years insulin-free. 'Right now, it's only available in research settings – and while the excitement is real, urgent work is still needed to ensure it reaches everyone who could benefit. 'That means securing a UK licence for teplizumab, establishing national screening programmes to identify people with early-stage type 1 diabetes before symptoms appear, and preparing the NHS to deliver this treatment at scale. 'Diabetes UK is proud to be at the forefront of these efforts – funding pioneering research and working closely with the NHS towards a future where immunotherapies become the first-line treatment for tackling the autoimmune attack at the root of type 1 diabetes.' Professor Richard Oram, consultant physician at the Royal Devon and professor at the University of Exeter, said: 'Excitingly, teplizumab is the first drug with the potential to delay type 1 diabetes, but needs to be given before clinical diagnosis due to high blood glucose. 'It is really important to find new and improved approaches for identifying individuals at elevated risk.'


Scottish Sun
2 hours ago
- Scottish Sun
Legendary bodybuilder needs emergency surgery for ‘infection in bloodstream' after pulling out of UK event
The surgery will take place in the next few days, Ronnie Coleman's family said STAR'S FEARS Legendary bodybuilder needs emergency surgery for 'infection in bloodstream' after pulling out of UK event Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) LEGENDARY bodybuilder Ronnie Coleman needs emergency surgery after suffering an "infection in his bloodstream", his family revealed. The 61-year-old, hailed as one of the sport's greatest ever competitors, was rushed to hospital last week and had to postpone his trip to the UK. Sign up for Scottish Sun newsletter Sign up 4 Ronnie Coleman will undergo emergency surgery, his family revealed Credit: Rex 4 The 61-year-old, who was admitted due to an infection, is also dealing with an 'additional underlying health matter' Credit: The Mega Agency 4 The former American bodybuilder is famous for winning the Mr. Olympia title eight times in a row Credit: AP The bodybuilder's family announced last Monday that Ronnie was "admitted to hospital" due to an "infection in his bloodstream". In an update on Monday, they said that doctors discovered an "additional underlying health matter" that will require him to undergo surgery. The family wrote: "At this time, Ronnie's overall condition remains serious but stable, with continued signs of gradual recovery. "His medical team is still actively working to identify the source of the infection, which can take several days to confirm through thorough testing. "During a recent round of evaluations, doctors identified an additional underlying health matter that will require a surgical procedure. "This procedure is expected to take place in these coming days, and the medical team is confident in their approach as part of Ronnie's broader care plan. "We remain hopeful and encouraged by Ronnie's resilience, and we are deeply grateful for the outpouring of support from around the world. "Please continue to keep Ronnie in your thoughts and prayers as we await the next stages of his recovery." Ronnie holds the record for the most Mr. Olympia titles - with eight. He also claimed 26 International Federation of Bodybuilding and Fitness titles before retiring in 2007. Bodybuilding legend 'Mr Japan' whose calves made Arnold Schwarzenegger jealous, dies aged 78 Concerns over his health first arose after he was forced to postpone a scheduled trip to the UK earlier this week. Ronnie shared the news in an Instagram post last week, writing: "Hey guys, I hate to break it to y'all, but I won't be able to make it out to the UK this week like I planned. "Unfortunately, I had a medical emergency and had to stick around here in the U.S. for treatment. "But don't worry… I'm in great hands, getting the best care, and I'm staying strong through it all. "I'll be back and better than ever, and I can't wait to get out there and see you all real soon!" His health update was shared on his Instagram account, which boasts nearly 12 million followers. Ronnie was inducted into the International Sports Hall of Fame in 2016. Two years later, the Netflix documentary Ronnie Coleman: The King - based on his life and career - was released.


Scottish Sun
4 hours ago
- Scottish Sun
NHS to use robots on obese patients during surgery as it's safest way to operate on them
Robotics is one of the Government's 'five big bets' on technology that will revolutionise the NHS ROBO DOC NHS to use robots on obese patients during surgery as it's safest way to operate on them Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) THE NHS will use surgical robots to get more fat Brits on the operating table because machines can work on people who are too high-risk for manual procedures. They use smaller instruments and enter through smaller incisions, and can be faster so patients do not need as much anaesthetic. Sign up for Scottish Sun newsletter Sign up 3 Staff using the new Versius robotic arm technology during a surgery at Milton Keynes NHS Hospital Credit: PA 3 Robotics is one of the Government's 'five big bets' on technology that will revolutionise the NHS Robotics is one of the Government's 'five big bets' on technology that will revolutionise the NHS. Ministers' 10-Year Plan for the health service, launched last week, said it will 'expand surgical robot adoption'. NHS watchdog the National Institute for Health and Care Excellence (Nice) has encouraged hospitals to invest more in surgical robots and use them more widely. A recent report by NHS England added: 'Robot-assisted surgery may improve access to surgery for people who are at higher risk, including people with a high body mass index.' Body mass index is a height-to-weight ratio, with any number higher than 30 classed as obese. About three in 10 adults in England are obese and this puts them at higher risk during operations and may even mean they can't have them. Bulky fat means it takes longer to conduct super-precise surgery and large patients need more anaesthetic and lose more blood. Top prostate surgeon Ben Challacombe, who works at Guy's and St Thomas' NHS Trust in London, said: 'Operating on obese patients is highly complex and more tricky. 'When you're obese you're much more likely to get an infection or to have breathing difficulties because your lungs are being squashed by other tissues. 'Robotic assistance means we can do more. Robot doctor that can perform surgery in space is destined for ISS 'We can do robotic surgery on much bigger patients than we could with traditional keyhole surgery.' Jeffrey Ahmed, a gynaecological surgeon at Chelsea and Westminster NHS Trust, said: 'Some patients are too obese to have an operation, because to do a big open operation on someone whose BMI is 65 subjects them to too much risk. 'The minimally invasive approach that we can do on the robot opens up the possibility of doing that kind of care for patients. 'I think it will be used more in the future. 'If you can't physically do an operation for a patient without a robot, then that's going to be the way to do it. 'You can't just not offer the patient surgery because you don't have access to a robot.' Robot-assisted surgery relies on qualified surgeons controlling the £1m machines with the usual medical team around the patient. There are about 140 machines in use in England and their use has rocketed from 35,000 operations in 2022 to 70,000 in 2024. Dr Chris Smith-Brown, from the Private Healthcare Information Network, added: 'We know that losing weight is not always possible. 'There is hope that obesity won't have to be a barrier to life-changing surgery.'